SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040138
Filing Date
2023-08-09
Accepted
2023-08-09 07:10:52
Documents
69
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aura-20230630.htm   iXBRL 10-Q 2837639
2 EX-31.1 aura-ex31_1.htm EX-31.1 22345
3 EX-31.2 aura-ex31_2.htm EX-31.2 22144
4 EX-32.1 aura-ex32_1.htm EX-32.1 22070
  Complete submission text file 0000950170-23-040138.txt   9765169

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aura-20230630_pre.xml EX-101.PRE 347895
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aura-20230630_lab.xml EX-101.LAB 491188
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aura-20230630.xsd EX-101.SCH 62544
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aura-20230630_def.xml EX-101.DEF 243688
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aura-20230630_cal.xml EX-101.CAL 47432
63 EXTRACTED XBRL INSTANCE DOCUMENT aura-20230630_htm.xml XML 1855756
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40971 | Film No.: 231153342
SIC: 2836 Biological Products, (No Diagnostic Substances)